Login to Your Account

Dementia drug discovery alliance making strides in U.K.

By Nuala Moran
Staff Writer

Friday, October 13, 2017

LONDON – A coordinated approach to dementia drug discovery, uniting academics, industry and public and private funders, is showing signs of success in focusing research, speeding translation and de-risking the field for pharma.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription